Catalyst Wire Dossier Catalyst Wire Dossier

Anoro Ellipta (umeclidinium/vilanterol)

umeclidinium/vilanterol · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anoro Ellipta (umeclidinium/vilanterol), covering 2016-03-03 to 2016-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium [Phase 3]

See pricing